Exploring immunomodulation by endocrine changes in Lady Windermere syndrome
- PMID: 30697704
- PMCID: PMC6422647
- DOI: 10.1111/cei.13265
Exploring immunomodulation by endocrine changes in Lady Windermere syndrome
Abstract
Lung disease due to nontuberculous mycobacteria (NTM) occurs with disproportionate frequency in postmenopausal women with a unique phenotype and without clinically apparent predisposing factors. Dubbed 'Lady Windermere syndrome', the phenotype includes low body mass index (BMI), tall stature and higher than normal prevalence of scoliosis, pectus excavatum and mitral valve prolapse. Although the pathomechanism for susceptibility to NTM lung disease in these patients remains uncertain, it is likely to be multi-factorial. A role for the immunomodulatory consequences of oestrogen deficiency and altered adipokine production has been postulated. Altered levels of adipokines and dehydroepiandrosterone have been demonstrated in patients with NTM lung disease. Case reports of NTM lung disease in patients with hypopituitarism support the possibility that altered endocrine function influences disease susceptibility. This paper catalogues the evidence for immunomodulatory consequences of predicted endocrine changes in Lady Windermere syndrome, with emphasis on the immune response to NTM. Collectively, the data warrant further exploration of an endocrine link to disease susceptibility in Lady Windermere syndrome.
Keywords: adipokines; hormones; immune response; nontuberculous mycobacteria; oestrogen.
© 2019 British Society for Immunology.
Conflict of interest statement
The authors have no personal, professional or financial conflicts of interest relevant to this paper.
Figures

Similar articles
-
Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease.Gend Med. 2010 Feb;7(1):5-18. doi: 10.1016/j.genm.2010.01.005. Gend Med. 2010. PMID: 20189150 Review.
-
Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. doi: 10.1164/rccm.201206-1035OC. Epub 2012 Nov 9. Am J Respir Crit Care Med. 2013. PMID: 23144328 Free PMC article.
-
Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease.J Formos Med Assoc. 2020 Jun;119 Suppl 1:S13-S22. doi: 10.1016/j.jfma.2020.05.001. Epub 2020 May 22. J Formos Med Assoc. 2020. PMID: 32451216 Review.
-
Susceptibility to nontuberculous mycobacterial lung disease.Eur Respir J. 2008 Jun;31(6):1322-33. doi: 10.1183/09031936.00140007. Eur Respir J. 2008. PMID: 18515557 Review.
-
Nontuberculous mycobacteria in women, young and old.Clin Chest Med. 2002 Sep;23(3):675-86. doi: 10.1016/s0272-5231(02)00010-2. Clin Chest Med. 2002. PMID: 12371003
Cited by
-
Autophagy and Host Defense in Nontuberculous Mycobacterial Infection.Front Immunol. 2021 Sep 6;12:728742. doi: 10.3389/fimmu.2021.728742. eCollection 2021. Front Immunol. 2021. PMID: 34552591 Free PMC article. Review.
-
Estrogen and bacterial infection.Front Immunol. 2025 Apr 29;16:1556683. doi: 10.3389/fimmu.2025.1556683. eCollection 2025. Front Immunol. 2025. PMID: 40364840 Free PMC article. Review.
-
The Rise of Non-Tuberculosis Mycobacterial Lung Disease.Front Immunol. 2020 Mar 3;11:303. doi: 10.3389/fimmu.2020.00303. eCollection 2020. Front Immunol. 2020. PMID: 32194556 Free PMC article. Review.
-
Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease.Front Immunol. 2022 Nov 10;13:1047781. doi: 10.3389/fimmu.2022.1047781. eCollection 2022. Front Immunol. 2022. PMID: 36439147 Free PMC article.
-
The impact of hormones on lung development and function: an overlooked aspect to consider from early childhood.Front Endocrinol (Lausanne). 2024 Sep 20;15:1425149. doi: 10.3389/fendo.2024.1425149. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39371928 Free PMC article. Review.
References
-
- Falkinham JO III. Environmental sources of nontuberculous mycobacteria. Clin Chest Med 2015; 36:35–41. - PubMed
-
- Griffith DE, Aksamit T, Brown‐Elliott BA et al An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416. - PubMed
-
- Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med 2015; 36:1–11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical